
- DRTP August 2019
- Volume 1633
- Issue 8
CDC Calls on Pharmacists to Aid HIV Epidemic
Pharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.
While
“The new data, released on National HIV Testing Day, underscore the urgent need to scale up HIV testing to end America’s HIV epidemic,” the CDC states. “The analysis of 2016-2017 data from a national population-based survey suggest most people are not getting the recommended screening, even in areas with a high burden of HIV.”
The study’s release follows an initiative spearheaded by the Trump Administration calling for a 75% reduction in new HIV cases over the next five years and a 90% reduction in a decade. The Health and Human Services (HHS) initiative “
- Investing in geographic hotspots through programs like the Ryan White HIV/AIDS Program and a community health center program to make pre-exposure prophylaxis (PrEP) more widely available to a high-risk population.
- Using data to address healthcare needs at the local level
- Establishing local teams to expand HIV prevention and treatment.
The initiative will target geographic areas with the highest number of new HIV cases including the 50 local jurisdictions and seven states with a high proportion of new HIV cases in rural areas, specifically: Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina.
Trending:
If funded, the HHS-led initiative is calling on CDC to take an active role with the Health Resources and Services Administration, Indian Health Service, NIH, Office of the HHS Assistant Secretary for Health, and the Substance Abuse and Mental Health Services Administration.
The most recent CDC findings on HIV include:
- Less than 30% of people considered “at risk of acquiring HIV” were tested in the past year.
- In the 50 local jurisdictions where more than half of HIV diagnoses occur, less than 35% of people recommended for annual HIV testing were tested in the past year.
- Only 26% of people living in rural areas (who were recommended for testing) had been tested for HIV in the past year.
CDC recommends people with specific risk factors be screened at least once a year. That includes:
- Sexually active gay, bisexual and other men who have sex with men;
- People who inject drugs;
- Anyone who has had more than one sex partner since their last HIV test;
- People who have been diagnosed with another sexually transmitted infection, hepatitis, or tuberculosis
“A negative HIV test result can lead to prevention options like PrEP, a medication to prevent HIV acquisition,” CDC says. “A positive result should lead that person to care and treatment, ideally on the day the diagnosis is made.
“HIV treatment reduces the amount of HIV in a person to a very low level-known as viral suppression or having an undetectable viral load. People who reach and maintain viral suppression have effectively no risk of transmitting HIV to others through sex,” CDC states.
The new study mentions promising novel approaches to increase access to HIV testing. These approaches included integrated and routinized HIV screening in a variety of healthcare settings, as well as scaling up partner notification and social/sexual network screening strategies, and mass distribution of HIV self-tests.
According to the
- HIV testing
- Treatment of HIV infection
- Treatment of HIV in key patient populations
- HIV treatment failure
- Management of HIV disease state complications
- Treatment and prevention of opportunistic infections
- Prevention of HIV infection
- HIV education
- Social services and HIV infection
- Professional engagement
Articles in this issue
about 6 years ago
Preventing Errors with High-Risk Medicationsover 6 years ago
Major Chains to Dominate Expanding CBD Marketover 6 years ago
Pharmacists Among Those Fired in Hospital Fentanyl Deaths Caseover 6 years ago
How Pharmacists Assist in Opioid Diversion Detectionover 6 years ago
Walmart Layoffs Impact Senior Staffover 6 years ago
Drug Shortages: Impact on U.S. Health SystemsNewsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.